This publication summarises a presentation given by Professor Prasad Kumarasinghe on hyperpigmentation disorders at the New Zealand Dermatological Society Annual Conference 2024. The talk covered the mechanisms underlying pigmentation, and common disorders of hyperpigmentation and their treatments, including the novel topical agent Melasyl (2-mercaptonicotinoyl glycine; 2-MNG). The presentation and this write-up were supported by La Roche Posay.
Please login below to download this issue (PDF)